GGrantIndex
Sort

51,570 grants matching autoimmune disease

Genetic Analysis of Inflammatory Responses in Wild Derived Mice

$769,698
Alexander Poltorak · Tufts University Boston · R01 · FY2020 · AI

Molecular Determinants of TLR Trafficking

$769,642
Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · AI

mRNA alternative polyadenylation in B cell development

$768,845
Yongsheng Shi · University Of California-Irvine · R01 · FY2025 · AI

The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus

$768,728
Carla M Cuda · Northwestern University At Chicago · R01 · FY2025 · AI

Trisomy 21 Model Atlas

$768,701
Matthew D Galbraith · University Of Colorado Denver · R24 · FY2024 · OD

B cell clonal selection in gut-associated germinal centers

$768,621
Gabriel D Victora · Rockefeller University · R01 · FY2021 · AI

B cell clonal selection in gut-associated germinal centers

$768,621
Gabriel D Victora · Rockefeller University · R01 · FY2020 · AI

Functions of IL-17 Family Cytokines and their Signaling Mechanisms in Health and Disease

$768,448
Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Developing new immunotherapies based of CD4 T cells

$768,394
Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

The Integrated Stress Response in Human Islets During Early T1D

$768,337
Raghavendra G Mirmira · University Of Chicago · U01 · FY2021 · DK

Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery

$768,331
Otto O Yang · University Of California Los Angeles · R01 · FY2020 · AI

Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery

$768,331
Otto O Yang · University Of California Los Angeles · R01 · FY2022 · AI

Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery

$768,331
Otto O Yang · University Of California Los Angeles · R01 · FY2021 · AI

Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery

$768,331
Otto O Yang · University Of California Los Angeles · R01 · FY2023 · AI

Aberrant DNA Repair and Lupus

$768,093
Joann B Sweasy · University Of Arizona · R35 · FY2023 · ES

Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial

$767,849
Margaret M Madeleine · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA

Johns Hopkins Rheumatic Diseases Resource-based Core Center

$767,757
Antony Rosen · Johns Hopkins University · P30 · FY2020 · AR

Engineered Immune Cells for T1D

$767,617
Everett Meyer · Stanford University · R01 · FY2024 · DK

Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever

$767,610
Manuel L Penichet · University Of California Los Angeles · R01 · FY2023 · AI

CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS

$767,592
Gerhard Wagner · Harvard Medical School · R01 · FY2024 · AI

MHC Proteins and Human Disease

$767,582
Harvard University · R01 · FY2002 · AI

Linking antibody sequences to function at the single-cell level using nanovial technology

$767,559
Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2023 · GM

Two-Stage Genome-Wide Association Study in Systemic Sclerosis

$767,520
Maureen Maureen Mayes · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · AR

Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere

$767,423
Paul John Norman · University Of Colorado Denver · R01 · FY2024 · AI

Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere

$767,423
Paul John Norman · University Of Colorado Denver · R01 · FY2025 · AI